A prognostic model for survival after salvage treatment with FLAG‐Ida +/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia
暂无分享，去创建一个
M. Sanz | M. Barrios | J. Serrano | J. Bergua | R. Rodríguez-Veiga | P. Montesinos | M. Sayas | D. Martínez-Cuadrón | G. Rodríguez-Macías | J. Prieto-Fernandez | M. Pérez-Encinas | C. Benavente | M. Martínez-Sánchez | Raimundo García | P. Fernández-Abellán | A. Simiele | A. Garcia-Huerta | Pilar Herrera-Puente | M. L. Amador-Barciela | Rosalía Riaza-Grau | P. Fernández‐Abellán